ARCpoint Inc
ARC
Minas Metals Ltd
MINA
Quri-Mayu Developments Ltd
QURI
KGL Resources Ltd
KGL.H
Alerio Gold Corp
ALE
CA Stock MarketDetailed Quotes
MYCO Mydecine Innovations Group Inc
- 0.010
- 0.0000.00%
15min DelayMarket Closed Dec 13 12:28 ET
617.55KMarket Cap-0.05P/E (TTM)
0.010High0.005Low505.80KVolume0.005Open0.010Pre Close5.04KTurnover0.11552wk High0.82%Turnover Ratio61.76MShares0.00552wk Low-0.2EPS TTM617.55KFloat Cap0.200Historical HighLossP/E (Static)61.76MShs Float0.005Historical Low-0.68EPS LYR50.00%Amplitude--Dividend TTM-0.04P/B1Lot Size--Div YieldTTM
Mydecine Innovations Group Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 82.63%1.65M | -0.75%2.28M | -83.80%626.55K | -40.21%9.55M | -60.17%2.48M | -60.79%902.65K | -24.80%2.3M | -13.94%3.87M | -29.62%15.97M | -40.31%6.21M |
| Selling and administrative expenses | -30.82%490.72K | -69.10%668.6K | -80.36%558.9K | -18.45%7.7M | -19.50%1.95M | -59.49%709.34K | -7.46%2.16M | -6.34%2.85M | -31.65%9.45M | -65.30%2.42M |
| -General and administrative expense | -30.82%490.72K | -69.10%668.6K | -80.36%558.9K | -18.45%7.7M | -19.50%1.95M | -59.49%709.34K | -7.46%2.16M | -6.34%2.85M | -31.65%9.45M | -65.30%2.42M |
| Research and development costs | 1,216.29%1.14M | 1,377.33%1.5M | -90.54%13.56K | -69.15%1.08M | -44.05%751.87K | -81.40%86.9K | -84.41%101.75K | -86.34%143.33K | -11.29%3.51M | -35.32%1.34M |
| Depreciation amortization depletion | --0 | --0 | --0 | -92.34%9.88K | -99.99%1 | -95.35%1.2K | -90.08%3.4K | -91.31%5.28K | -45.21%128.86K | -92.14%8.53K |
| -Depreciation and amortization | --0 | --0 | --0 | -92.34%9.88K | -99.99%1 | -95.35%1.2K | -90.08%3.4K | -91.31%5.28K | -45.21%128.86K | -92.14%8.53K |
| Other operating expenses | -86.79%13.9K | 241.61%112.5K | -93.81%54.09K | -73.93%751.55K | -109.17%-224.06K | 80.73%105.21K | -8.86%32.93K | 152.60%873.65K | -38.36%2.88M | 95.09%2.44M |
| Operating profit | -82.63%-1.65M | 0.75%-2.28M | 83.80%-626.55K | 40.21%-9.55M | 60.17%-2.48M | 60.79%-902.65K | 24.80%-2.3M | 13.94%-3.87M | 29.59%-15.97M | 40.27%-6.21M |
| Net non-operating interest income (expenses) | -56.62%-386.72K | -52.87%-366.31K | -49.19%-350.47K | -42.91%-1.3M | -155.26%-581.28K | -10.13%-246.92K | -0.49%-239.62K | -6.20%-234.92K | -344.10%-911.59K | -288.77%-227.72K |
| Non-operating interest expense | 56.62%386.72K | 52.87%366.31K | 49.19%350.47K | 42.91%1.3M | 155.26%581.28K | 10.13%246.92K | 0.49%239.62K | 6.20%234.92K | 344.10%911.59K | 288.77%227.72K |
| Other net income (expenses) | 232.29%44.17K | -179.91%-18.39K | 99.39%-38.66K | -987.55%-10.1M | -297.15%-3.73M | 93.53%-33.39K | -96.64%23.01K | -590.09%-6.36M | 264.02%1.14M | 286.45%1.89M |
| Gain on sale of security | 232.29%44.17K | -211.44%-25.65K | 99.04%-49.48K | -392.13%-5.14M | -99.16%18.46K | 83.31%-33.39K | -96.64%23.01K | -458.69%-5.15M | 664.08%1.76M | 446.18%2.2M |
| Special income (charges) | --0 | --7.26K | 100.84%10.82K | -289.70%-1.23M | 542,400.00%5.43K | --0 | --0 | ---1.29M | -23,063.54%-316.21K | -99.97%1 |
| -Less:Other special charges | ---- | ---7.26K | -299.35%-10.82K | ---53.11K | ---5.43K | ---- | ---- | --5.43K | ---- | ---- |
| -Less:Write off | --0 | --0 | --0 | --1.29M | --0 | --0 | --0 | --1.29M | --0 | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---316.21K | ---- |
| Other non-operating income (expenses) | ---- | ---- | ---- | -1,116.08%-3.72M | ---3.75M | ---- | ---- | --79.77K | 20.05%-306.12K | ---- |
| Income before tax | -68.31%-1.99M | -5.99%-2.67M | 90.29%-1.02M | -33.04%-20.95M | -48.97%-6.78M | 61.12%-1.18M | 3.65%-2.52M | -85.59%-10.46M | 33.24%-15.75M | 60.33%-4.55M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -68.31%-1.99M | -5.99%-2.67M | 90.29%-1.02M | -126.46%-20.95M | -405.21%-6.78M | 64.39%-1.18M | 3.65%-2.52M | -85.59%-10.46M | 67.99%-9.25M | 120.42%2.22M |
| Net income continuous operations | -68.31%-1.99M | -5.99%-2.67M | 90.29%-1.02M | -33.04%-20.95M | -48.97%-6.78M | 61.12%-1.18M | 3.65%-2.52M | -85.59%-10.46M | 33.24%-15.75M | 60.33%-4.55M |
| Net income discontinuous operations | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 222.22%6.5M | 1,038.41%6.78M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -68.31%-1.99M | -5.99%-2.67M | 90.29%-1.02M | -126.46%-20.95M | -405.21%-6.78M | 64.39%-1.18M | 3.65%-2.52M | -85.59%-10.46M | 67.99%-9.25M | 120.42%2.22M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -68.31%-1.99M | -5.99%-2.67M | 90.29%-1.02M | -126.46%-20.95M | -405.21%-6.78M | 64.39%-1.18M | 3.65%-2.52M | -85.59%-10.46M | 67.99%-9.25M | 120.42%2.22M |
| Diluted earnings per share | 25.00%-0.03 | 60.00%-0.04 | 96.43%-0.02 | 36.45%-0.68 | -125.80%-0.129 | 88.57%-0.04 | 71.43%-0.1 | 53.33%-0.56 | 82.66%-1.07 | 122.42%0.5 |
| Basic earnings per share | 25.00%-0.03 | 60.00%-0.04 | 96.43%-0.02 | 36.45%-0.68 | -125.80%-0.129 | 88.57%-0.04 | 71.43%-0.1 | 53.33%-0.56 | 82.66%-1.07 | 122.42%0.5 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.